Suppr超能文献

肝动脉化疗栓塞联合门静脉内细胞毒性药物输注——肝转移瘤区域化疗的新概念

[Chemoembolization of the hepatic artery combined with intraportal cytostatic infusion--a new concept in the regional chemotherapy of liver metastases].

作者信息

Seifart W, Waigand J, Booss H J, Slisow W, Uhlig F

出版信息

Arch Geschwulstforsch. 1986;56(6):445-50.

PMID:3548641
Abstract

At present international the regional cytostatic chemotherapy for hepatic metastases is used by the intraarterial way. Newest methods are the technically very pretentious intraarterial perfusion with venous hemofiltration and the chemo-embolization of the hepatic artery requiring meanwhile an adjuvant systemic chemotherapy because the chemo-embolization influences only the arterially supplied part of the metastases. By the combination of the transumbilical intraportal chemotherapy formerly developed in the Central Institute for Cancer Research Berlin-Buch with the intraarterial chemo-embolization it is possible to reduce considerably the technical expenditure and to increase the regional concentration of cytostatics simultaneous avoiding the load of the whole organism. The bases of this new method and the technical procedure are discussed.

摘要

目前在国际上,肝转移瘤的区域细胞毒性化疗采用动脉内给药方式。最新的方法是技术要求很高的动脉内灌注联合静脉血液滤过以及肝动脉化疗栓塞术,同时需要辅助全身化疗,因为化疗栓塞术仅影响转移瘤的动脉供血部分。通过将柏林-布赫中央癌症研究所先前研发的经脐门静脉化疗与动脉内化疗栓塞术相结合,可以大幅降低技术成本,并同时提高细胞毒性药物的局部浓度,避免对整个机体造成负担。本文讨论了这种新方法的基础及技术操作过程。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验